Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma

Published:2023-07-15 Issue:14 Volume:149 Page:12677-12690
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Lv Liemei,Zhang Yu,Kong Ran,Wang Cong,Wang Xin,Zhou Xiangxiang

Funder

National Natural Science Foundation

Key Research and Development Program of Shandong Province

Translational Research Grant of NCRCH

Academic Promotion Programme of Shandong First Medical University

Taishan Scholars Program of Shandong Province

Shandong Provincial Engineering Research Center of Lymphoma

China Postdoctoral Science Foundation

Shandong Provincial Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05018-0.pdf

Reference51 articles.

1. Aglietti RA, Dueber EC (2017) Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions. Trends Immunol 38:261–271. https://doi.org/10.1016/j.it.2017.01.003

2. Ahechu P et al (2018) NLRP3 inflammasome: a possible link between obesity-associated low-grade chronic inflammation and colorectal cancer development. Front Immunol 9:2918. https://doi.org/10.3389/fimmu.2018.02918

3. Bagratuni T et al (2016) TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma. Br J Haematol 172:44–47. https://doi.org/10.1111/bjh.13786

4. Blasco MT, Gomis RR (2020) PD-L1 controls cancer pyroptosis. Nat Cell Biol 22:1157–1159. https://doi.org/10.1038/s41556-020-00582-w

5. Carpio C et al (2020) Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier. Blood 135:996–1007. https://doi.org/10.1182/blood.2019002395

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential;Biomedicine & Pharmacotherapy;2024-06

2. Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review;Critical Reviews in Oncology/Hematology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3